Molecular Epidemiological Characterization of Staphylococcus aureus and Staphylococcus argenteus Clinical Isolates from a National Tertiary Care Hospital in Myanmar: Co-Isolation of Multiple Clones and Identification of Novel Staphylocoagulase Genotype
Microbial Drug Resistance · 2023
DOI: 10.1089/mdr.2022.0191 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbial Drug Resistance, 2023. Verfasst von Win Kalayar Kyaw und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Technology, University of Medical Technology, Yangon, Myanmar. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
Spread of antimicrobial resistance and virulence factors among Staphylococcus aureus / Staphylococcus argenteus poses a potential public health concern in Myanmar. In this study, a total of 226 clinical isolates of S. aureus ( n = 211) and S. argenteus ( n = 15) collected in Yangon General Hospital during a two-year period were analyzed for their antimicrobial susceptibility and genetic features. Methicillin-resistant S. aureus (MRSA) accounted for 19% of S. aureus isolates, associated with mostly staphylococcal cassette chromosome mec (SCC mec ) type IV, or V. Panton-Valentine leukocidin (PVL) genes were detected in methicillin-susceptible S. aureus (MSSA) at significantly higher rate (39%) than in MRSA (22%). Among MRSA, ST361 (clonal complex [CC] 361), ST772 (CC1), and ST239 (CC8) were frequently identified, while the most common clone in MSSA was ST2990 (CC1), followed by ST121 and CC8 comprising five STs. Novel coagulase gene genotype XVI was identified in four MSSA isolates. All the S. argenteus isolates were assigned to ST2250 and mecA negative, including only one PVL-positive isolate. MSSA and S. argenteus were co-isolated from two patients, while two different MSSA clones were simultaneously identified in eight patients. This study revealed clonal diversity and genetic characteristics of current MRSA/MSSA/ S. argenteus clinical isolates in the national tertiary care hospital in Myanmar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Laboratory Technology, University of Medical Technology, Yangon, Myanmar.
- Department of Hygiene, Sapporo Medical University School of Medicine, Sapporo, Japan.
- Yangon Children's Hospital, Yangon, Myanmar.
- Department of Microbiology, University of Medicine 2, Yangon, Myanmar.
- Yangon General Hospital, Yangon, Myanmar.
ORCID-Profile: Meiji Soe Aung
Zitieren
APA
Kyaw, W. K., Aung, M. S., San, T., Maw, W. W., Mu, K. K., Mon, W. L. Y., Than, M. M., San, N., Than, C. C., Urushibara, N., & Kobayashi, N. (2023). Molecular Epidemiological Characterization of Staphylococcus aureus and Staphylococcus argenteus Clinical Isolates from a National Tertiary Care Hospital in Myanmar: Co-Isolation of Multiple Clones and Identification of Novel Staphylocoagulase Genotype. Microbial Drug Resistance. https://doi.org/10.1089/mdr.2022.0191
Vancouver
Kyaw WK, Aung MS, San T, Maw WW, Mu KK, Mon WLY, et al. Molecular Epidemiological Characterization of Staphylococcus aureus and Staphylococcus argenteus Clinical Isolates from a National Tertiary Care Hospital in Myanmar: Co-Isolation of Multiple Clones and Identification of Novel Staphylocoagulase Genotype. Microbial Drug Resistance. 2023. doi:10.1089/mdr.2022.0191
BibTeX
@article{Kyaw2023,
author = {Kyaw, Win Kalayar and Aung, Meiji Soe and San, Thida and Maw, Win Win and Mu, Khin Khin and Mon, Win Lei Yee and Than, Mie Mie and San, Nilar and Than, Cho Cho and Urushibara, Noriko and Kobayashi, Nobumichi},
title = {Molecular Epidemiological Characterization of Staphylococcus aureus and Staphylococcus argenteus Clinical Isolates from a National Tertiary Care Hospital in Myanmar: Co-Isolation of Multiple Clones and Identification of Novel Staphylocoagulase Genotype},
journal = {Microbial Drug Resistance},
year = {2023},
doi = {10.1089/mdr.2022.0191}
}
EUVIMED